0001104659-22-127084.txt : 20221214 0001104659-22-127084.hdr.sgml : 20221214 20221214201157 ACCESSION NUMBER: 0001104659-22-127084 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221212 FILED AS OF DATE: 20221214 DATE AS OF CHANGE: 20221214 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Dudley Robert Michael CENTRAL INDEX KEY: 0001854161 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40363 FILM NUMBER: 221463464 MAIL ADDRESS: STREET 1: C/O TRANSCODE THERAPEUTICS STREET 2: 6 LIBERTY SQUARE #2382 CITY: BOSTON STATE: MA ZIP: 02109 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Transcode Therapeutics, Inc. CENTRAL INDEX KEY: 0001829635 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 811065054 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6 LIBERTY SQUARE STREET 2: #2382 CITY: BOSTON STATE: MA ZIP: 02109 BUSINESS PHONE: 857-301-6857 MAIL ADDRESS: STREET 1: 6 LIBERTY SQUARE STREET 2: #2382 CITY: BOSTON STATE: MA ZIP: 02109 4 1 tm2232745-2_4seq1.xml OWNERSHIP DOCUMENT X0306 4 2022-12-12 0 0001829635 Transcode Therapeutics, Inc. RNAZ 0001854161 Dudley Robert Michael C/O TRANSCODE THERAPEUTICS, INC. 6 LIBERTY SQUARE, #2382 BOSTON MA 02109 1 1 1 0 Chief Executive Officer Stock Option (Right to Buy) 0.51 2022-12-12 4 A 0 135000 0 A 2032-12-11 Common Stock 135000 135000 D Thirty-three percent (33%) of the Stock Options shall vest and become exercisable on the one year anniversary of Vesting Commencement Date (December 1, 2022). Thereafter, the remaining sixty-seven percent (67%) of the Stock Options shall vest and become exercisable in 24 equal monthly installments on the last day of each such month following the first anniversary of the Vesting Commencement Date, provided the Reporting Person continues to have a Service Relationship with the Company on each vesting date. /s/ Thomas A. Fitzgerald, as Attorney-in-Fact 2022-12-14